Taki Chemical (4025) Fundamentals 2026 — P/E 13.2x, Revenue Analysis | SniperIQ
Taki Chemical (4025) is a JP-listed Basic Materials company in Chemicals with a market capitalization of ¥44.9B, trading at ¥5380.00 on the JPX. This SniperIQ fundamentals page covers Taki Chemical's valuation (P/E 13.2x, P/B 1.0x), profitability (net margin 8.0%), revenue (¥42.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Taki Chemical's market cap?
Taki Chemical (4025) has a market capitalization of approximately ¥44.9B, trading at ¥5380.00 on the JPX. Market cap moves with the live share price.
What is Taki Chemical's P/E ratio?
Taki Chemical's trailing twelve-month P/E ratio is 13.2x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Taki Chemical?
Taki Chemical runs a net profit margin of 8.0%, a gross margin of 24.9%, and an operating margin of 8.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Taki Chemical generate?
Taki Chemical reported revenue of ¥42.0B for fiscal year 2025, with net income of ¥3.3B and earnings per share (EPS) of 388.99. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Taki Chemical pay a dividend?
Taki Chemical offers a trailing dividend yield of about 1.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Taki Chemical financially healthy?
Taki Chemical carries a debt-to-equity ratio of 0.03x and a current ratio of 2.71x, with a market beta of 0.40. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Taki Chemical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Taki Chemical (4025) the key facts are: market cap ¥44.9B, P/E 13.2x, revenue ¥42.0B, 52-week range 2833-5620. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Taki Chemical's full fundamentals live
Get Taki Chemical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.